Table 1. Summary of currently available OA therapies.
| Type of treatment | Example | Pros | Cons | Reference |
|---|---|---|---|---|
| Non-pharmacological | Exercise, therapeutic ultrasound, phototherapy, thermotherapy, electrical stimulation, acupuncture | Analgesia, joint function restoration, wide access, recommended to all patients | Long-term treatment, large variation in therapeutic effects | 85, 86 |
| Pharmacologic | NSAIDs (e.g., glucocorticoids, COX-2 inhibitors), Chondroprotective drugs (e.g., chondroitin sulfate, HA) | Affordable, analgesia, anti-inflammation, wide access, effective on most OA patients | Side-effects on brain, gastrointestinal and cardiovascular systems, little pro-regenerative and disease-modifying effects | 87-92 |
| Biological | Platelet-rich plasma, MSC-based therapy | Providing necessary factors to aid cartilage regeneration, improve OA injury and patient’s life quality | Complex manufacture, expensive, fibrocartilage formation, more effective in symptom relief than regeneration | 93, 94 |
| Surgical | Microfracture, autologous graft, partial/total knee arthroplasty | Effective end-stage OA therapies, necessary for late-OA patients to reduce pain, prevent disability and improve life quality | Invasive, costly, some require re-surgeries | 95-97 |
Note: COX-2: cyclooxygenase-2; HA: hyaluronic acid; MSC: mesenchymal stem cell; NSAIDs: nonsteroidal anti-inflammatory drugs; OA: osteoarthritis.